32,161 Shares in Oscar Health, Inc. $OSCR Bought by Fortis Capital Advisors LLC

Key Points

• Fortis Capital Advisors LLC has acquired 32,161 shares of Oscar Health, Inc., valued at approximately $690,000, indicating growing institutional interest in the company.
• Multiple analysts have downgraded Oscar Health’s stock ratings, with Piper Sandler reducing their price target from $14.00 to $13.00, reflecting a general bearish sentiment on the stock.
• Insider Mario Schlosser sold 395,000 shares of Oscar Health, leading to a significant 44.08% decrease in his ownership stake.

Fortis Capital Advisors LLC purchased a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 32,161 shares of the company's stock, valued at approximately $690,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Hsbc Holdings PLC lifted its stake in Oscar Health by 2.7% in the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock worth $313,000 after acquiring an additional 632 shares during the period. Tempus Wealth Planning LLC lifted its stake in Oscar Health by 6.7% in the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock worth $189,000 after acquiring an additional 906 shares during the period. Focus Partners Wealth raised its holdings in Oscar Health by 1.8% in the first quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after purchasing an additional 949 shares in the last quarter. Xponance Inc. lifted its position in Oscar Health by 7.1% during the first quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after buying an additional 1,029 shares during the period. Finally, CWM LLC lifted its position in Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Insider Activity

In related news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider directly owned 501,148 shares in the company, valued at approximately $9,236,157.64. This trade represents a 44.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 24.39% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Piper Sandler lowered their price objective on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Barclays lowered their price objective on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price objective for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Finally, Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Four equities research analysts have rated the stock with a Hold rating and six have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Oscar Health currently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Price Performance

OSCR opened at $21.67 on Friday. The stock has a 50-day moving average price of $17.05 and a 200-day moving average price of $15.58. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The firm has a market cap of $5.60 billion, a PE ratio of -26.75 and a beta of 1.89. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $22.78.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. The firm had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.Oscar Health's quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.20 EPS. Sell-side analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.